Vincenzo Cerundolo

Vincenzo Cerundolo's AcademicInfluence.com Rankings

Vincenzo Cerundolo

Biology

#9625

World Rank

#12849

Historical Rank

Immunology

#577

World Rank

#596

Historical Rank

biology Degrees

Download Badge

Biology

Vincenzo Cerundolo's Degrees

PhD Immunology University of Oxford
Bachelors Biochemistry University of Pavia

Why Is Vincenzo Cerundolo Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vincenzo Cerundolo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections (2002) (1736)
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. (1998) (1566)
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis (2013) (1394)
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells (2010) (694)
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. (2000) (651)
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes (1998) (592)
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. (1998) (534)
High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals (1999) (534)
NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells 1 (2003) (506)
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. (1999) (487)
Assembly of MHC class I molecules analyzed in vitro (1990) (471)
Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection (2004) (463)
High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo (1998) (441)
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level (2005) (423)
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. (2000) (420)
Presentation of viral antigen controlled by a gene in the major histocompatibility complex (1990) (396)
Harnessing invariant NKT cells in vaccination strategies (2009) (364)
Phase I study in melanoma patients of a vaccine with peptide‐pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells (2000) (359)
Classification of current anticancer immunotherapies (2014) (357)
Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer (1992) (342)
Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction (2010) (341)
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. (2008) (334)
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. (1998) (287)
The crystal structure of human CD1d with and without α-galactosylceramide (2005) (281)
Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood (1998) (271)
Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. (2006) (266)
Structural and kinetic basis for heightened immunogenicity of T cell vaccines (2005) (266)
Mature CD8(+) T lymphocyte response to viral infection during fetal life. (2003) (264)
Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains (2002) (262)
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A (2010) (258)
Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses (2011) (257)
Autophagy is a critical regulator of memory CD8+ T cell formation (2014) (257)
Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. (2002) (246)
Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold (2003) (245)
Biology of CD1- and MR1-restricted T cells. (2014) (244)
Selection of T Cell Clones Expressing High-Affinity Public TCRs within Human Cytomegalovirus-Specific CD8 T Cell Responses1 (2005) (234)
In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes (1999) (231)
Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time (2010) (229)
Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency (2007) (227)
Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells1 (2000) (225)
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation (2007) (224)
CpG-matured Murine Plasmacytoid Dendritic Cells Are Capable of In Vivo Priming of Functional CD8 T Cell Responses to Endogenous but Not Exogenous Antigens (2004) (224)
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. (2013) (223)
Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. (1999) (221)
Dendritic cells: a journey from laboratory to clinic (2004) (214)
Peptide-induced conformational change of the class I heavy chain (1991) (213)
An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions (1999) (212)
Tracking T cells with tetramers: new tales from new tools (2002) (210)
Immunopolarization of CD4+ and CD8+ T Cells to Type-1–Like is Associated with Melanocyte Loss in Human Vitiligo (2003) (209)
B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo (2008) (208)
Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation (2007) (207)
Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions (2003) (207)
Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography (2001) (206)
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity (2008) (191)
Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum (1995) (191)
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. (2004) (186)
The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules (1991) (185)
Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols1 (2002) (181)
Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL1 (2000) (180)
Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. (2007) (179)
TAP deficiency syndrome (2000) (179)
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. (2004) (178)
CD169+ MACROPHAGES PRESENT LIPID ANTIGENS TO MEDIATE EARLY ACTIVATION OF INVARIANT NKT CELLS IN LYMPH NODES (2010) (177)
Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells (1999) (169)
Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a (2016) (168)
Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. (2007) (166)
A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response1 (2000) (162)
Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals (2007) (160)
The proteasome‐specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells (1997) (157)
Vα24-JαQ-Independent, CD1d-Restricted Recognition of α-Galactosylceramide by Human CD4+ and CD8αβ+ T Lymphocytes1 (2002) (148)
Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells1 (2000) (147)
Cutting Edge: Endoplasmic Reticulum Stress Licenses Macrophages To Produce Mature IL-1β in Response to TLR4 Stimulation through a Caspase-8– and TRIF-Dependent Pathway (2014) (146)
Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport (1995) (145)
Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases (2006) (145)
Rational design of indoleamine 2,3-dioxygenase inhibitors. (2010) (144)
HIV‐1 down‐regulates the expression of CD1d via Nef (2006) (143)
Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3 (1999) (141)
CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients (1999) (140)
Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition (1992) (140)
Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules (1999) (135)
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood (2016) (130)
Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. (2003) (129)
Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1 (2017) (126)
Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response1 (2004) (123)
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. (2000) (122)
Cord Factor and Peptidoglycan Recapitulate the Th17-Promoting Adjuvant Activity of Mycobacteria through Mincle/CARD9 Signaling and the Inflammasome (2013) (122)
NAADP Activates Two-Pore Channels on T Cell Cytolytic Granules to Stimulate Exocytosis and Killing (2012) (120)
Rational development of high-affinity T-cell receptor-like antibodies (2009) (120)
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. (2000) (120)
Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E61 (2001) (119)
The Regulatory Role of Invariant NKT Cells in Tumor Immunity (2015) (118)
Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection (2003) (114)
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. (1999) (111)
Autophagy Controls Acquisition of Aging Features in Macrophages (2015) (110)
High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining 1 (2003) (108)
Immunodominance of Poxviral-Specific CTL in a Human Trial of Recombinant-Modified Vaccinia Ankara1 (2005) (106)
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12. (2000) (106)
Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells (2000) (103)
Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors (2006) (100)
T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. (2009) (100)
Immunoregulatory Role of CD1d in the Hydrocarbon Oil-Induced Model of Lupus Nephritis1 (2003) (100)
Tetramer-Guided Analysis of TCR β-Chain Usage Reveals a Large Repertoire of Melan-A-Specific CD8+ T Cells in Melanoma Patients1 (2000) (98)
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. (1999) (97)
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming (2001) (96)
The location of splenic NKT cells favours their rapid activation by blood-borne antigen (2012) (95)
Dendritic Cell Function Can Be Modulated through Cooperative Actions of TLR Ligands and Invariant NKT Cells1 (2007) (94)
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence (2005) (93)
The crystal structure of human CD1d with and without alpha-galactosylceramide. (2005) (93)
The Crystal Structure of Human CD1b with a Bound Bacterial Glycolipid12 (2003) (91)
Essential role for autophagy during invariant NKT cell development (2014) (90)
MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A (2018) (90)
Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors (2006) (89)
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. (2001) (89)
Cutting Edge: Nonglycosidic CD1d Lipid Ligands Activate Human and Murine Invariant NKT Cells1 (2008) (89)
Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. (2000) (88)
Bee venom processes human skin lipids for presentation by CD1a (2015) (87)
A Dominant Role for the Immunoproteasome in CD8+ T Cell Responses to Murine Cytomegalovirus (2011) (87)
Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue (2000) (86)
Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8+ and CD4+ T-Cell Responses (2007) (85)
Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC1 (2001) (84)
The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells (2019) (82)
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. (1999) (80)
Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences (2015) (80)
Role of Immunoproteasomes in Cross-Presentation1 (2006) (80)
RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. (2000) (80)
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. (2004) (78)
Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region (2007) (78)
BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. (2005) (77)
Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. (1998) (76)
Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1 (2009) (76)
DOCK8 is critical for the survival and function of NKT cells. (2013) (76)
Centriole polarisation to the immunological synapse directs secretion from cytolytic cells of both the innate and adaptive immune systems (2011) (76)
HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. (2005) (74)
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. (1999) (74)
Prostaglandin E2 suppresses the differentiation of retinoic acid–producing dendritic cells in mice and humans (2011) (74)
An antigen-targeted approach to adoptive transfer therapy of cancer. (1999) (73)
Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. (2010) (73)
Kinetics and mechanics of two-dimensional interactions between T cell receptors and different activating ligands. (2012) (72)
MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases (2015) (71)
Modulation of cancer-specific immune responses by amino acid degrading enzymes. (2017) (71)
Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells (2017) (71)
In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire (2015) (70)
Antigen Potency and Maximal Efficacy Reveal a Mechanism of Efficient T Cell Activation (2011) (70)
Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system (2011) (69)
A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. (1993) (69)
Human autoreactive T cells recognize CD1b and phospholipids (2015) (69)
CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef1 (2005) (69)
BCR repertoire sequencing: different patterns of B cell activation after two Meningococcal vaccines (2015) (68)
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite–derived phospholipase (2016) (67)
HLA-A*0201, HLA-A*1101, and HLA-B*0702 Transgenic Mice Recognize Numerous Poxvirus Determinants from a Wide Variety of Viral Gene Products1 (2005) (67)
B and CTL responses to the ALK protein in patients with ALK‐positive ALCL (2006) (66)
A quantitative assay of peptide‐dependent class I assembly (1991) (65)
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response (2018) (65)
Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells (2004) (64)
Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. (2013) (64)
Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity (1987) (63)
Diverse Endogenous Antigens for Mouse NKT Cells: Self-Antigens That Are Not Glycosphingolipids (2011) (63)
Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. (2002) (62)
Identification of a TAP-Independent, Immunoproteasome-Dependent CD8+ T-Cell Epitope in Epstein-Barr Virus Latent Membrane Protein 2 (2003) (60)
Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface 1 (2003) (60)
The Crystal Structure of Human CD1b with a Bound Bacterial Glycolipid (2004) (59)
Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses (2015) (58)
Recent advances in processing and presentation of CD1 bound lipid antigens. (2010) (57)
B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation (2016) (56)
Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. (2003) (55)
Cytoskeletal Control of Antigen-Dependent T Cell Activation (2019) (55)
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. (1999) (55)
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141+XCR1+ dendritic cells (2011) (54)
Structural and functional aspects of lipid binding by CD1 molecules. (2008) (54)
Expression of MHC Class I–Related Chain B (MICB) Molecules on Renal Transplant Biopsies (2006) (53)
NKG2A, a New Kid on the Immune Checkpoint Block (2018) (53)
NY‐CO‐58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer (2010) (52)
Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense. (2006) (49)
Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL1 (2007) (48)
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model (2020) (47)
Invariant NKT cells modulate the suppressive activity of Serum Amyloid A-differentiated IL-10-secreting neutrophils (2010) (46)
A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. (1997) (45)
Structural requirements for the peptide‐induced conformational change of free major histocompatibility complex class I heavy chains (1992) (44)
Elevated and cross‐responsive CD1a‐reactive T cells in bee and wasp venom allergic individuals (2015) (44)
Ca2+ Release from the Endoplasmic Reticulum of NY-ESO-1–Specific T Cells Is Modulated by the Affinity of TCR and by the Use of the CD8 Coreceptor (2010) (44)
Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I–Related Molecule–Dependent and Cytokine-Driven Pathways (2017) (43)
Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology. (2000) (43)
Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells. (2005) (42)
CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1 (1991) (41)
Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells. (2016) (41)
Naturally processed peptides (1990) (41)
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection (2020) (40)
Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy (2017) (40)
Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection. (2006) (40)
Globosides but Not Isoglobosides Can Impact the Development of Invariant NKT Cells and Their Interaction with Dendritic Cells (2012) (39)
NY‐ESO‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO‐1 fowlpox virus (2015) (39)
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer (2019) (38)
Biological function of the soluble CEACAM1 protein and implications in TAP2‐deficient patients (2004) (38)
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza (2017) (38)
Precise tuning of gene expression levels in mammalian cells (2019) (37)
The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice. (2002) (36)
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis (1989) (36)
Exploiting retrograde transport of Shiga‐like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway (1999) (36)
Ligand-dependent downregulation of MR1 cell surface expression (2020) (35)
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses (2019) (35)
Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation (2013) (35)
Malignant melanoma and bone resorption (2006) (34)
IDO Induces Expression of a Novel Tryptophan Transporter in Mouse and Human Tumor Cells (2011) (34)
Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balance. (2010) (34)
Viral Immunity: Cross-Priming with the Help of TLR3 (2005) (34)
High Frequency of Cytolytic 21-Hydroxylase–Specific CD8+ T Cells in Autoimmune Addison’s Disease Patients (2014) (34)
Differential processing of influenza nucleoprotein in human and mouse cells (1998) (33)
Association of the human invariant chain with H‐2 Db class I molecules (1992) (33)
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes (2000) (32)
The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells (2016) (32)
Human T-Cell Leukemia Virus Type 1 Tax Protein Binds to Assembled Nuclear Proteasomes and Enhances Their Proteolytic Activity (2001) (32)
CD1d-dependent endogenous and exogenous lipid antigen presentation. (2015) (31)
Effect of epitope flanking residues on the presentation of N‐terminal cytotoxic T lymphocyte epitopes (1999) (31)
Gene therapy meets vaccine development. (2004) (31)
Interaction Between Invariant NKT Cells and Myeloid-derived Suppressor Cells in Cancer Patients: Evidence and Therapeutic Opportunities (2012) (30)
Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. (2002) (30)
BPI–ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram‐negative bacterial infections (2003) (30)
The influence of macrophage inflammatory protein‐1α on protective immunity mediated by antiviral cytotoxic T cells (2003) (29)
Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide (2009) (29)
Exogenous Peptides Delivered by Ricin Require Processing by Signal Peptidase for Transporter Associated with Antigen Processing-Independent MHC Class I-Restricted Presentation1 (2002) (27)
Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies. (2019) (27)
Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. (1998) (26)
The use of HLA class I tetramers to design a vaccination strategy for melanoma patients (2002) (26)
Intestinal DC in migrational imprinting of immune cells (2013) (25)
Harnessing NKT cells for therapeutic applications. (2007) (25)
Amide Analogues of CD1d Agonists Modulate iNKT-Cell-Mediated Cytokine Production (2012) (25)
CD1d presentation of glycolipids (2008) (25)
Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues (2012) (24)
A closer look at CD1d molecules: new horizons in studying NKT cells. (2007) (24)
The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies (2018) (23)
The role of invariant NKT cells at the interface of innate and adaptive immunity. (2010) (23)
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses (2019) (23)
Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses (2020) (22)
Linking Inflammation to Natural Killer T Cell Activation (2009) (22)
Differences in phenotype and function between spontaneously occurring melan‐A‐, tyrosinase‐ and influenza matrix peptide‐specific CTL in HLA‐A*0201 melanoma patients (2005) (22)
Nonglycosidic Agonists of Invariant NKT Cells for Use as Vaccine Adjuvants (2009) (22)
Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses (2018) (22)
Aberrant Selection and Function of Invariant NKT Cells in the Absence of AP-1 Transcription Factor Fra-21 (2009) (21)
Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation (2019) (21)
Active nuclear transcriptome analysis reveals inflammasome-dependent mechanism for early neutrophil response to Mycobacterium marinum (2017) (21)
Phage display‐derived recombinant antibodies with TCR‐like specificity against α‐galactosylceramide and its analogues in complex with human CD1d molecules (2008) (20)
HLA-E–restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities (2021) (20)
Novel CD8+ T Cell Antagonists Based on β2-Microglobulin* (2002) (20)
Immunotherapy of melanoma (2001) (20)
Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics (2020) (20)
Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo. (2007) (20)
Cutting Edge: Human Myelomonocytic Cells Express an Inhibitory Receptor for Classical and Nonclassical MHC Class I Molecules (1998) (19)
A Single-Chain H-2Db Molecule Presenting an Influenza Virus Nucleoprotein Epitope Shows Enhanced Ability at Stimulating CD8+ T Cell Responses In Vivo 1 (2009) (19)
Binding Strength and Dynamics of Invariant Natural Killer Cell T Cell Receptor/CD1d-Glycosphingolipid Interaction on Living Cells by Single Molecule Force Spectroscopy* (2011) (19)
The Immune Modulating Properties of Mucosal-Associated Invariant T Cells (2020) (18)
Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials (2015) (18)
Short peptides assist the folding of free class I heavy chains in solution (1992) (18)
Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition. (1999) (18)
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. (2017) (18)
MHC‐peptide‐specific antibodies reveal inefficient presentation of an HLA‐A*0201‐restricted, Melan‐A‐derived peptide after active intracellular processing (2007) (17)
Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells. (1998) (17)
Gaps in knowledge and prospects for research of adjuvanted vaccines. (2015) (17)
Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann‐Pick disease type C (2012) (17)
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma (2020) (17)
The chemical synthesis, stability and activity of MAIT cell prodrug agonists that access MR1 in recycling endosomes. (2020) (16)
Non‐glycosidic compounds can stimulate both human and mouse iNKT cells (2016) (16)
Human Invariant NKT Cells Are Required for Effective In Vitro Alloresponses1 (2005) (15)
Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes. (2001) (15)
Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses1 (2007) (15)
Functional activity in vivo of effector T cell populations III. Protection against Moloney murine sarcoma virus (M‐MSV)‐induced tumors in T cell deficient mice by the adoptive transfer of a M‐MSV‐specific cytolytic T lymphocyte clone (1987) (15)
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity (2020) (15)
Discovery of Salmonella trehalose phospholipids reveals functional convergence with mycobacteria (2019) (15)
Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells (2019) (14)
The Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone To Direct Human TLR7 into Endosomes (2015) (14)
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses (2021) (14)
Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells. (2003) (14)
Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes (2018) (13)
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation (2021) (13)
Monitoring CD 8 T cell responses to NY-ESO-1 : correlation of humoral and cellular immune responses (2017) (13)
T lymphocytes need less than 3 min to discriminate between peptide MHCs with similar TCR-binding parameters (2015) (12)
Snapin promotes HIV‐1 transmission from dendritic cells by dampening TLR8 signaling (2017) (12)
Capturing the antigen landscape: HLA-E, CD1 and MR1. (2019) (12)
T cells work together to fight cancer. (1999) (11)
Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non‐muscle‐invasive disease (2019) (11)
Design, Synthesis, and Functional Activity of Labeled CD1d Glycolipid Agonists (2013) (11)
IFN-γ Exposes a Cryptic Cytotoxic T Lymphocyte Epitope in HIV-1 Reverse Transcriptase (1999) (11)
Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells. (2011) (11)
Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes. (1987) (10)
NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses (2019) (10)
An open invitation to the cancer immunology community. (2012) (10)
Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients (2000) (9)
Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation (2020) (9)
Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation (2011) (9)
Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⁺ T cell specificity. (2014) (8)
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell–mediated toxicity against glioblastoma (2022) (8)
Differential processing of HLA A2-restricted HIV type 1 cytotoxic T lymphocyte epitopes. (2002) (8)
NY‐ESO‐1 protein glycosylated by yeast induces enhanced immune responses (2010) (7)
Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infection (2016) (7)
Immune monitoring in cancer immunotherapy. (2000) (7)
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. (1989) (7)
NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-presentation and CD8 T Cell Responses (2019) (7)
Diverse Streptococcus pneumoniae strains drive a MAIT cell response through MR1-dependent and cytokine-driven pathways (2017) (7)
Immunotherapy of colorectal cancer. (2002) (6)
Cytomegalovirus-Specific CD 8 T Cell High-Affinity Public TCRs within Human Selection of T Cell Clones Expressing (2005) (6)
A Novel Approach to Antigen-Specific Deletion of CTL with Minimal Cellular Activation Using a 3 Domain Mutants of MHC Class I / Peptide Complex express (2001) (6)
Tumour immunology: T cells work together to fight cancer (1999) (5)
Antigen presentation. Naturally processed peptides. (1990) (5)
Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma. (2014) (5)
The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation (2021) (5)
Erratum: The location of splenic NKT cells favours their rapid activation by blood-borne antigen (The EMBO Journal (2012) 31, (2378-2390) DOI: 10.1038/emboj.2012.87) (2012) (5)
Lack of dendritic cell maturation by the plant toxin ricin (2004) (5)
Measles Virus Transmembrane Fusion Protein Synthesized De Novo or Presented in Immunostimulating Complexes Is Endogenously Processed for HLA Class I- and Class H-restricted Cytotoxic T Cell Recognition By Robert S. van Binnendijk,* Card A. van Baalen,* (2005) (5)
Deep analysis of the USP18-dependent ISGylome and proteome unveils important roles for USP18 in tumour cell antigenicity and radiosensitivity (2020) (5)
T cell receptors get back to basics (2007) (5)
Investigating Systemic Immunity to Typhoid and Paratyphoid Fever: Characterising the response to re-challenge in a controlled human infection model (2017) (4)
Antigen processing and presentation. The role of the endoplasmic reticulum. (1993) (4)
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells (2020) (4)
Erratum to: B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation (2016) (4)
Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide (2021) (4)
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC). (2019) (4)
Inflammasome-dependent IL-1 beta production is critical for complete Freund's adjuvant-induced helper T cell polarization (2010) (4)
Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones. (1985) (4)
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases (2005) (4)
Mature CD 8 + T lymphocyte response to viral infection during fetal life (2018) (4)
Kinetics and mechanics of 2 D interactions between T cell receptors and different activating ligands (2014) (4)
Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics. (2020) (4)
Analysis of frequency and phenotype of antigen-specific T cells. (2009) (3)
Colon Carcinoma-Specific CTL Modulation of CD103 Expression on Human (2007) (3)
Novel CD8+ T cell antagonists based on beta 2-microglobulin. (2002) (3)
NKT-dependent B-cell activation in Gaucher disease. (2015) (3)
Nonprofessional APC Lymphocytes as Compared with + Superior MelanA-Specific CD 8 Mature Dendritic Cells Prime Functionally (2001) (3)
Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action (2020) (2)
Isolation of a human allo-peptide presented by HLA-B51 molecules. (1995) (2)
The Kinetics of Association of Peptides with MHC Class 1 Molecules (1993) (2)
B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation (2016) (2)
Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice. (1984) (2)
Invariant NKT Cell-Based Vaccine Strategies (2012) (2)
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC) (2019) (2)
Receptors Tumor Cells Using High Affinity T Cell NY-ESO-1 / LAGE-1-Derived Epitopes on Quantifying and Imaging (2006) (2)
Nephritis Hydrocarbon Oil-Induced Model of Lupus Immunoregulatory Role of CD 1 d in the (2003) (2)
and Invariant NKT Cells Ligands through Cooperative Actions of TLR Dendritic Cell Function Can Be Modulated (2013) (2)
HLA-E restricted, HIV-1 suppressing, Gag specific CD8+ T cells offer universal vaccine opportunities (2020) (2)
Reply to "Failure to detect production of IL-10 by activated human neutrophils" (2011) (2)
Antigen presentation and the association of class-I molecules. (1991) (2)
This information is current as Epitope from Human Papillomavirus 16 E 6 Carcinomas Limit the Presentation of a CTL Antigen Processing Defects in Cervical Cerundolo and (2001) (2)
[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function]. (2008) (2)
A CD1 lipidomic analysis determines the structures of human CD1b scaffold lipids and its function to enhance mycobacterial antigen presentation (106.43) (2012) (1)
AGGREGATION OF RANTES IS RESPONSIBLE FOR THE ACTIVATION OF LEUKOCYTES (1999) (1)
Aberrant alternative splicing of TAP2 in two adults with HSV1-infection and recurrent strokes: new insights into the peptide-loading complex (2008) (1)
Erratum: HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products (Journal of Immunology (2005) 175 (5504-5515)) (2005) (1)
Author response: Autophagy is a critical regulator of memory CD8+ T cell formation (2014) (1)
Precise tuning of gene expression output levels in mammalian cells (2018) (1)
MAIT cells activate dendritic cells to promote T follicular helper cell differentiation and humoral immunity (2022) (1)
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model (2020) (1)
Analysis of arginine metabolism in acute myeloid leukaemia to provide insights into tumour immune escape strategies (2017) (1)
MAIT cells activate dendritic cells to promote TFH cell differentiation and induce humoral immunity (2023) (1)
MRC Human Immunology Unit (2017) (1)
Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to melanocyte transformation (2017) (1)
Inflammasome-dependent IL-1β production is critical for complete Freund’s adjuvant-induced helper T cell polarization (136.44) (2010) (1)
In vitro transfer of ricin toxicity by tumor-specific cytotoxic T lymphocytes (1985) (0)
Although Mature Clinical Data From (0)
Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells (2019) (0)
Cell Surface Absence of an Interaction between pMHCI on CTL Activation and Occurs in the Binding : This Is Paralleled by Their Effects Peptide-MHC Class I ( pMHCI ) Multimer Anti-CD 8 Antibodies Can Inhibit or Enhance (2003) (0)
Active nuclear transcriptome analysis reveals inflammasome-dependent mechanism for early neutrophil response to Mycobacterium marinum (2017) (0)
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer (2023) (0)
A novel pathway of recognition of skin-lipid antigens by T cells (2015) (0)
Potential role for CD1d restricted T-cells in the immunopathology of sarcoidosis (2003) (0)
Abstract LB-080: USP18 modulates the ISGylome, immune signaling and sensitizes tumor cells to irradiation and CTL recognition (2020) (0)
Is Temperature Dependent Peptide-MHC Class I Tetrameric Complexes Specificity of CTL Interactions with (1999) (0)
Erratum to: B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation (2016) (0)
Signaling and the Inflammasome Mycobacteria through Mincle/CARD9 the Th17-Promoting Adjuvant Activity of Cord Factor and Peptidoglycan Recapitulate (2013) (0)
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors (2023) (0)
Correction: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing (2008) (0)
Human CD4 Negative NKT Cells Potently Suppress Alloreactive Responses in a TGF-β and IL-10-Independent Manner. (2004) (0)
352: Analysis of Renal Cell Cancer Tumour Antigen Carbonic Anhydrase 9 Specific Cytotoxic T Lymphocytes from a Healthy HLA-A2 Donor (2005) (0)
Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes (1998) (0)
Plasma cell antibody repertoire analysis following administration of meningococcal polysaccharide and protein-polysaccharide conjugate vaccines: evidence of distinct patterns of B cell activation (2014) (0)
The role of invariant NKT cells in enhancing antigen specific T and B cell responses (2005) (0)
T T Cell Help during Primary CD8 + CD4Vivo Does Not Replace the Requirement for Increasing the Survival of Dendritic Cells In (2007) (0)
Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins. (1991) (0)
ProteinComposition and Stability of the Antigenic Epitope Is Affected by Proteasome Subunit Generation of an Immunodominant CTL (1999) (0)
Direct induction by melanoma, prostate cancer and Ewing's sarcoma tumour cells of osteoclast formation by a RANKL-independent mechanism (2005) (0)
Deletion of the deISGylating enzyme USP 18 enhances 1 tumour cell antigenicity and radiosensitivity 2 3 (2020) (0)
CTL Response Encoding NY-ESO-1 Induces an Effective Intravenous Injection of a Lentiviral Vector (2004) (0)
Faculty Opinions recommendation of Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. (2016) (0)
Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8 (cid:1) and CD4 (cid:1) T-Cell Responses (cid:1) (2007) (0)
Chronic granulomatosis lesions in patients with low surface expression of MHC class I molecules. (1999) (0)
Running title: A passive transfer model of CASPR2 antibodies (2019) (0)
Induction of antigen-specific immune responses in melanoma patients after vaccination with peptide-pulsed dendritic cells. (1999) (0)
Precise tuning of gene expression levels in mammalian cells (2019) (0)
Correction: Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport (European Journal of Immunology (1995) 25 (561-562)) (1995) (0)
Increased populations of regulatory T cells in peripheral blood and tumor infiltrating lymphocytes in colorectal cancer patients (2005) (0)
Cells through Direct Interaction with Dendritic Responses to Soluble Antigen In Vivo T Cell + and CD8 + NKT Cells Enhance CD4 (2003) (0)
PO-1821: Investigating immune microenvironment effects of radiotherapy in pre-clinical prostate cancer models (2020) (0)
MHC-peptide specific antibodies reveal inefficient presentation of an antigenic Melan-A derived peptide after active intracellular processing (2006) (0)
Role of natural killer T cells in the pathogenesis of dengue infections (2015) (0)
Processing of human TLR7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. (P1244) (2013) (0)
NefDisrupt Proteasomal Processing of HIV-1 T Cell Epitope-Flanking Mutations + CD 8 Cerundolo and (2005) (0)
CD8 on the Cell Surface and of an Interaction between pMHCI Activation and Occurs in the Absence Paralleled by Their Effects on CTL (pMHCI) Multimer Binding: This Is Enhance Peptide-MHC Class I Anti-CD8 Antibodies Can Inhibit or (2010) (0)
A tale of actin and lipid antigen presentation - A nano tango (2017) (0)
The role of invariant natural killer T (iNKT) cells in modulating the lung inflammatory response during influenza A virus infection (2013) (0)
The location of splenic NKT cells favours their rapid activation by blood‐borne antigen (2013) (0)
Active Tumor-Specific Immune Response CTL Identifies Melanoma Patients with an A Shift in the Phenotype of Melan-A-Specific (2000) (0)
Tetramer Staining Identified by CD8-Independent High Avidity Antigen-Specific CTL (2010) (0)
Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T-cells. (2023) (0)
Immunoresponse to Wilms Tumor antigen-1 (WT-1) in CML patients. (2000) (0)
Bound Bacterial Glycolipid The Crystal Structure of Human CD 1 b with a (2004) (0)
CELLULAR AND HUMORAL MECHANISMS OF OSTEOCLAST FORMATION AND RESORPTION IN MELANOMA METASTASES (2006) (0)
patients The mechanisms controlling NK cell autoreactivity in TAP2-deficient (2009) (0)
Cell Surface andof an Interaction between pMHCI Activation and Occurs in the Absence Paralleled by Their Effects on CTL ( pMHCI ) Multimer Binding : This Is Enhance Peptide-MHC Class I Anti-CD 8 Antibodies Can Inhibit (2003) (0)
Short title: Early cytolytic & transcriptional activity in CTLs (2016) (0)
Erratum: Kinetics and mechanics of two-dimensional interactions between T cell receptors and different activating ligands (Biophysical Journal (2012) 102 (248-257)) (2014) (0)
Deficiency in Sphingolipids Has No Effect on Self-antigen Presentation to Invariant NKT Cells (134.17) (2009) (0)
University of Birmingham The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells (2016) (0)
Generation and enrichment of antigen-specific cytotoxic t lymphocytes for adoptive transfer in tumor immunotherapy (2000) (0)
CD1b in complex with Phophatidylinositol (2002) (0)
Ligand-dependent modulation of MR1-restricted antigen presentation (2022) (0)
Publisher Correction: Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses (2019) (0)
Mutations in a putative hepatitis B virus HLA-A1 cytotoxic T lymphocyte epitope. Affect binding and correlate with disease severity. (1996) (0)
CD1b in complex with GM2 ganglioside (2002) (0)
Encoding a MelanA Peptide Analogue Responses by Recombinant Vaccinia Induction of Potent Antitumor CTL (1999) (0)
Nonapeptidische ny-eso-1 derivatives and their use (2000) (0)
CD 8-Independent Tetramer Staining High Avidity Antigen-Specific CTL Identified Vincenzo Cerundolo (2003) (0)
Vaccination Protocols Immune Response Induced by Prime-Boost Competition Between CTL Narrows the (2002) (0)
Filaggrin inhibits house dust mite phospholipase generation of CD1a lipid antigens for recognition by T cells (2016) (0)
The P5-ATPase ATP13A1 modulates MR1-mediated antigen presentation (2021) (0)
Harnessing invariant NKT-cells to enhance antigen specific immune responses (2014) (0)
10mer Crystal Structure of chicken MHC class I haplotype B21 (2008) (0)
Proceedings of research in clinical practice 2011. (2012) (0)
Primary Dendritic Cells Maturation of Monocyte-Derived and Invariant T Cells Induces CD40L-Dependent Activation of Human Mucosal-Associated (2017) (0)
HEPCIDIN REGULATION DURING ACUTE INFECTIONS (2013) (0)
T Cells + Memory CD8 Efficient Activation of Influenza A-Specific Requirement of Mature Dendritic Cells for (2000) (0)
Analysis of HIV-1 gag Peptides with a Quantitative Peptide-Dependent Class I Assembly Assay (1992) (0)
Application of HLA class I single chain trimers for leukaemia immunotherapy (2008) (0)
CD1a-restricted T cells and atopic dermatitis (2015) (0)
for Effective In Vitro Alloresponses Human Invariant NKT Cells Are Required (2005) (0)
Mechanisms of induction and modulation of the pro-inflammatory cytokine interleukin-1beta (2012) (0)
Memory CD8+ T Cells Efficient Activation of Influenza A-Specific Requirement of Mature Dendritic Cells for (2013) (0)
MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A (2018) (0)
Tumor therapy by adoptive transfer of ricin-treated cytotoxic T lymphocytes in mice (1985) (0)
Design , synthesis , and functional activity of labeled CD 1 d glycolipid agonists (2013) (0)
Processing of HIV-1 Nef Mutations Disrupt Proteasomal T Cell Epitope-Flanking + CD8 (2010) (0)
Interactions Between MAIT Cells and Dendritic Cells. (2020) (0)
Monocyte-Derived Dendritic Cells Melanoma Patients by Mature + Inducible in Terminal Stage HLA-A 2 . 1 Peptide-Specific Cytotoxic T Cells Are Mage-3 and Influenza-Matrix (2000) (0)
of three diff erent human CD1d-α- galactosylceramide-specifi c T cell receptors (2006) (0)
Depletion of the CD1d-Restricted NKT Cells Suppresses In Vitro Alloreactivity: A Possible Means To Prevent aGVHD. (2004) (0)
The role of tryptophan and the mTOR pathway in T cell fate determination (2014) (0)
The influence of invariant natural killer T cells on myeloid-derived suppressor cell generation and function (2011) (0)
Publisher Correction: Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses (2019) (0)
Differential processing of an influenza nucleoprotein epitope in human and murine cells (1997) (0)
Peptides binding to HLA antigens derived from an antigen, and applications. (2000) (0)
Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models (2020) (0)
Recombinant single-cycle influenza virus as a new tool to augment antitumour immunity with immune checkpoint inhibitors (2021) (0)
Prime-boost vaccination strategies with melanoma poly-epitope constructs (2003) (0)
Harnessing Invariant Natural Killer T Cells to Abolish the Suppressive Activity of Myeloid-derived Suppressor Cells and Restore Melanoma-specific Immune Response (2009) (0)
The Actin Cytoskeleton Controls the Activation of Invariant Natural Killer T Cells by Fine-Tuning CD1d Nanoscale Aggregation on Antigen Presenting Cells (2014) (0)
The Crystal Structure of Human CD1d with and without alpha-Galactosylceramide Bound (2005) (0)
Nonclassical MHC Class I Molecules Express an Inhibitory Receptor for Classical and Cutting Edge: Human Myelomonocytic Cells (1998) (0)
Tumor-Reactive CTL Analogues Capable of Improved Stimulation Identification of NY-ESO-1 Peptide and Vincenzo (2000) (0)
MP-20.09: Natural T cell responses to tumour antigen CA9 in a cohort of renal cell carcinoma patients (2006) (0)
Modulating the immune system by amino acid depletion - IDO and beyond (2011) (0)
Transcription Factor Fra-2 NKT Cells in the Absence of AP-1 Aberrant Selection and Function of Invariant (2009) (0)
Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses (2018) (0)
A case of primary immunodeficiency due to a defect of the MHC class I processing and presentation pathway (1997) (0)
Harnessing the immune system to reject cancers through genetic modifications of tumour cells (2015) (0)
Novel minigene vaccine stimulates CD8+ memory inflation to control growth of murine colorectal tumor (2020) (0)
Monitoring tumor antigen-specific cytolytic T lymphocytes with fluorescent tetramers in melanoma (1998) (0)
Vaccinia Ankara in a Human Trial of Recombinant-Modified Immunodominance of Poxviral-Specific CTL (2005) (0)
NY-ESO-1 Nonapeptidderivater and applications of these (2000) (0)
Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy (2022) (0)
Addendum: Precise tuning of gene expression levels in mammalian cells (2019) (0)
by CD8-Independent Tetramer Staining High Avidity Antigen-Specific CTL Identified (2013) (0)
Addendum: Precise tuning of gene expression levels in mammalian cells (2019) (0)
GlycosphingolipidsNKT Cells: Self-Antigens That Are Not Diverse Endogenous Antigens for Mouse (2010) (0)
Immunisation with a lentivector that targets tumour antigen expression to dendritic cells induces potent CD 8 + and CD 4 + T cell responses (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vincenzo Cerundolo?

Vincenzo Cerundolo is affiliated with the following schools: